Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock

Author： Matyal R. Vin Y. Delude R. Lee C. Creasey A. Fink M.

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.27, Iss.8, 2001-08, pp. : 1274-1280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tissue Factor Pathway Inhibitor‐Coated Stents Inhibit Restenosis in a Rabbit Carotid Artery Model

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 6, 2015-12 ,pp. : 353-359

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Insulin to Decrease Septic Shock-Induced Myocardial Depression in a Porcine Model

By Levenbrown Yosef Penfil Scott Rodriguez Elena Zhu Yan Hossain Jobayer Bhat A. Hesek Anne O’Neil Karen Tobin Kelly Shaffer Thomas

Inflammation, Vol. 36, Iss. 6, 2013-12 ,pp. : 1494-1502

Springer Publishing Company

Access to resources Recommend Favorite

New insights into the biology of tissue factor pathway inhibitor

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S200-S207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Unfractionated Heparin, Low Molecular Weight Heparin and Both Combined for Releasing Total and Free Tissue Factor Pathway Inhibitor

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 5, 1999-07 ,pp. : 229-235

Karger

Access to resources Recommend Favorite

The role of Syk/IĸB‐α/NF‐ĸB pathway activation in the reversal effect of BAY 61‐3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan‐induced non‐septic shock

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 45, Iss. 2, 2018-02 ,pp. : 155-165

John Wiley & Sons Inc

Access to resources Recommend Favorite